104958-59-0

Upstream product

• 461-17-6 1,1,1-trifluoro-4-iodo-butane 
• 619-44-3 methyl 4-iodobenzoate 
• 122310-47-8 3,3,3-prifluoropropyl-4-bromophenylcarbinol 
• 67-56-1 methanol 
• 103945-68-2 4-n-(4,4,4-trifluorobutyl)benzoic acid 
• 104958-58-9 1-bromo-4-(4,4,4-trifluorobutyl)benzene 
• 1122-91-4 4-bromo-benzaldehyde 

Downstream Products

• 1254113-94-4 methyl 4-(4,4,4-trifluorobutyl)cyclohexanecarboxylate 
• 104958-62-5 4-cyanophenyl trans-4-(4,4,4-trifluorobutyl)cyclohexanecarboxylate 
• 104958-56-7 trans-e,e-4-(4,4,4-trifluorobutyl)cyclohexanecarboxylic acid 

Relevant academic research and scientific papers

INDAZOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS

The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for e

INDAZOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS

The present invention is directed to indazole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for e

FLUORINE-CONTAINING LIQUID CRYSTALS. X. 4-(POLYFLUOROALKYL)BENZOIC AND CYCLOHEXANECARBOXYLIC ACIDS AND THEIR 4-CYANOPHENYL ESTERS

4-(3,3,3-Trifluoropropyl)benzoic, 4-(4,4,4-trifluorobutyl)benzoic, and cyclohexanecarboxylic acids and their 4-cyanophenyl esters were synthesized.The temperatures, character, and types of phase transitions of the mesogenic compounds depend to a significa